Home > Financial Ratios > SAMRAT PHARMACHEM

SAMRAT PHARMACHEM
EBIT Growth

    Back to All Ratios
SAMRAT PHARMACHEM is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

SAMRAT PHARMACHEM Last 5 Year EBIT Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) 229.27-86.50-2.11181.6027.46

What is the latest EBIT Growth ratio of SAMRAT PHARMACHEM ?

The latest EBIT Growth ratio of SAMRAT PHARMACHEM is 229.27 based on Mar2025 Standalone results.
Year EBIT Growth
Mar2025229.27
Mar2024-86.50
Mar2023-2.11
Mar2022181.60
Mar202127.46

How is EBIT Growth of SAMRAT PHARMACHEM Trending?

Years EBIT Growth % Change
Mar2025 229.27
Positive
Mar2024 -86.5
Negative
Mar2023 -2.11
Negative
Mar2022 181.6
561.33
Mar2021 27.46 -

Other Financial Ratios of SAMRAT PHARMACHEM


Compare EBIT Growth ratio of peers of SAMRAT PHARMACHEM

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM ₹62.8 Cr 0.7% 0.2% -43.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹423,195.0 Cr 3% 9.5% 3.1% Stock Analytics
DIVIS LABORATORIES ₹169,849.0 Cr 1.7% 3.1% 5.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹149,586.0 Cr 4.7% 11.7% 41.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,054.0 Cr 2.1% 6.7% 11.6% Stock Analytics
CIPLA ₹108,703.0 Cr 1.3% 1.3% -9.4% Stock Analytics


SAMRAT PHARMACHEM Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SAMRAT PHARMACHEM

0.7%

0.2%

-43.5%

SENSEX

-1.7%

0.5%

8.3%


You may also like the below Video Courses